Vertex Pharmaceuticals Aktie

Kaufen
Verkaufen
377,30 EUR -54,70 EUR -12,66 %
395,49 USD -1,08 USD -0,27 %
nachbörslich
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 111,16 Mrd. EUR

KGV 29,28 Div. Rendite 0,00%

WKN 882807

ISIN US92532F1003

Symbol VRTX


Vertex Pharmaceuticals Aktie Analyse

05.01.09 Vertex Pharmaceuticals buy Piper Jaffray & Co.
26.11.08 Vertex Pharmaceuticals outperform Credit Suisse Group
21.11.08 Vertex Pharmaceuticals buy Merriman Curhan Ford & Co
12.11.08 Vertex Pharmaceuticals buy Piper Jaffray & Co.
30.10.08 Vertex Pharmaceuticals buy Merriman Curhan Ford & Co
28.10.08 Vertex Pharmaceuticals hold Citigroup Corp.
27.10.08 Vertex Pharmaceuticals positive Susquehanna Financial Group, LLLP
26.09.08 Vertex Pharmaceuticals buy Needham & Company, LLC
26.09.08 Vertex Pharmaceuticals market outperform JMP Securities LLC
03.09.08 Vertex Pharmaceuticals perform Oppenheimer & Co. Inc.
22.08.08 Vertex Pharmaceuticals outperform Cowen and Company, LLC
09.07.08 Vertex Pharmaceuticals outperform Cowen and Company, LLC
10.06.08 Vertex Pharmaceuticals outperform Leerink Swann LLC
06.06.08 Vertex Pharmaceuticals positive Susquehanna Financial Group, LLLP
05.06.08 Vertex Pharmaceuticals outperform Leerink Swann LLC
04.06.08 Vertex Pharmaceuticals market perform JMP Securities LLC
22.05.08 Vertex Pharmaceuticals buy Pacific Growth Equities, LLC
29.04.08 Vertex Pharmaceuticals buy UBS AG
25.04.08 Vertex Pharmaceuticals outperform Leerink Swann LLC
11.04.08 Vertex Pharmaceuticals market outperform JMP Securities LLC
01.04.08 Vertex Pharmaceuticals outperform Robert W. Baird & Co. Incorporated
01.04.08 Vertex Pharmaceuticals market perform Wachovia Securities, LLC
01.04.08 Vertex Pharmaceuticals positive Susquehanna Financial Group, LLLP
11.03.08 Vertex Pharmaceuticals neutral Merriman Curhan Ford & Co
13.02.08 Vertex Pharmaceuticals buy UBS AG
29.01.08 Vertex Pharmaceuticals market outperform JMP Securities
25.01.08 Vertex Pharmaceuticals hold Citigroup Corp.
24.01.08 Vertex Pharmaceuticals buy UBS AG
16.01.08 Vertex Pharmaceuticals buy Banc of America Sec.
16.01.08 Vertex Pharmaceuticals neutral Robert W. Baird & Co. Incorporated
04.01.08 Vertex Pharmaceuticals underperform Wachovia Sec
09.11.07 Vertex Pharmaceuticals buy Goldman Sachs Group Inc.
05.11.07 Vertex Pharmaceuticals market perform Rodman & Renshaw
31.10.07 Vertex Pharmaceuticals buy UBS AG
19.10.07 Vertex Pharmaceuticals neutral Cowen and Company, LLC
12.10.07 Vertex Pharmaceuticals outperform Cowen and Company, LLC
01.10.07 Vertex Pharmaceuticals neutral Merrill Lynch
04.09.07 Vertex Pharmaceuticals buy Stifel, Nicolaus & Co., Inc.
08.08.07 Vertex Pharmaceuticals outperform Cowen & Co
25.07.07 Vertex Pharmaceuticals buy Stifel Nicolaus & Co.
24.07.07 Vertex Pharmaceuticals Global Biotech Investing
26.06.07 Vertex Pharmaceuticals buy Stifel Nicolaus & Co.
23.04.07 Vertex Pharmaceuticals hold Needham & Co
17.04.07 Vertex Pharmaceuticals buy UBS
16.04.07 Vertex Pharmaceuticals market outperform Rodman & Renshaw
27.03.07 Vertex Pharmaceuticals sector outperform CIBC World Markets
02.02.07 Vertex Pharmaceuticals buy UBS
02.02.07 Vertex Pharmaceuticals buy Citigroup
02.02.07 Vertex Pharmaceuticals Buy UBS
16.01.07 Vertex Pharmaceuticals neutral Susquehanna Financial